GSDMD and diabetic kidney disease: Since GSDMD-N-mediated pore formation facilitates the release of interleukin-1β (IL-1β) and IL-18—hallmark features of pyroptosis—we observed significantly elevated urinary IL-1β and IL-18 levels in DKD patients (Figures 1D, E).